[Are there any cost-benefit limits in connection with neonatal care?].
Lindroth
Magnus
M
D003362:Cost-Benefit Analysis; D015199:Extracorporeal Membrane Oxygenation / Q000191:economics*; D006801:Humans; D007231:Infant, Newborn; D015931:Intensive Care, Neonatal / Q000191:economics*; D009569:Nitric Oxide / Q000008:administration & dosage / Q000191:economics; D010102:Oxygen Inhalation Therapy / Q000191:economics*; D013548:Sweden
D009569:Nitric Oxide